Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001196243 | SCV001366798 | uncertain significance | Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits | 2019-07-26 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2,PP3. |
Ambry Genetics | RCV004033460 | SCV004915067 | uncertain significance | Inborn genetic diseases | 2023-10-20 | criteria provided, single submitter | clinical testing | The c.1998C>A (p.S666R) alteration is located in exon 9 (coding exon 9) of the CACNA1G gene. This alteration results from a C to A substitution at nucleotide position 1998, causing the serine (S) at amino acid position 666 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |